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Abstract
Background: Assessing safety outcomes is critical to inform optimal scale-up of voluntary medical male circumcision
(VMMC) programs. Clinical trials demonstrated adverse event (AE) rates from 1.5 to 8 %, but we have limited data on
AEs from VMMC programs.
Methods: A group problem-solving, quality improvement (QI) project involving retrospective chart audits, case-
conference AE classification, and provider training was conducted at a VMMC clinic in Malawi. For each identified
potential AE, the timing, assessment, treatment, and resolution was recorded, then a clinical team classified each
event for type and severity. During group discussions, VMMC providers were queried regarding lessons learned
and challenges in providing care. After baseline evaluation, clinicians and managers initiated a QI plan to improve
AE assessment and management. A repeat audit 6 months later used similar methods to assess the proportions
and severity of AEs after the QI intervention.
Results: Baseline audits of 3000 charts identified 418 possible AEs (13.9 %), including 152 (5.1 %) excluded after
determination of provider misclassification. Of the 266 remaining AEs, the team concluded that 257 were procedure-
related (8.6 AEs per 100 VMMC procedures), including 6 (0.2 %) classified as mild, 218 (7.3 %) moderate, and 33 (1.1 %)
severe. Structural factors found to contribute to AE rates and misclassification included: provider management of post-
operative inflammation was consistent with national guidelines for urethral discharge; available antibiotics were from
the STI formulary; providers felt well-trained in surgical skills but insecure in post-operative assessment and care. After
implementation of the QI plan, a repeat process evaluating 2540 cases identified 115 procedure-related AEs (4.5 AEs
per 100 VMMC procedures), including 67 (2.6 %) classified as mild, 28 (1.1 %) moderate, and 20 (0.8 %) severe. Reports
of AEs decreased by 48 % (from 8.6 to 4.5 per 100 VMMC procedures, p < 0.001). Reports of moderate-plus-severe
(program-reportable) AEs decreased by 75 % (from 8.4 to 1.9 per 100 VMMC procedures, p < 0.001).
Conclusions: AE rates from our VMMC program implementation site were within the range of clinical trial
experiences. A group problem-solving QI intervention improved post-operative assessment, clinical management, and
AE reporting. Our QI process significantly improved clinical outcomes and led to more accurate reporting of overall
and program-reportable AEs.
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Background
Male circumcision reduces the risk of HIV acquisition by
men through heterosexual intercourse by approximately
60 % [1–3], prompting public health programs to rapidly
scale-up voluntary medical male circumcision (VMMC)
services in countries with high HIV prevalence [4]. In sub-
Saharan Africa, the current goal set forth by the World
Health Organization (WHO) and UNAIDS is to circumcise
80 % of 15–49 year old males by delivering over 20 million
circumcisions to avert more than 3 million new HIV infec-
tions by 2015; a further 8.4 million VMMC procedures are
required to meet 2025 targets of 80 % coverage [5]. After
adopting VMMC programming in 2011, Malawi was
expected to complete over 2 million procedures by the end
of 2015 [6], in a setting with limited health infrastructure;
just 0.02 physicians and 0.28 nurse/midwives per 1000 indi-
viduals [7]. By the end of 2014, VMMC programs in Malawi
had achieved only 8 % of the 2015 VMMC target [8]. There
is a tremendous push to rapidly expand VMMC services in
order to reach short-term and longer-term goals.
As VMMC delivery scales-up rapidly in resource-limited
health systems, it is important to assess adverse events (AE)
to inform safe and effective program implementation. Ran-
domized clinical trials of VMMC demonstrated AE rates
ranging from 1.5 to 8 % [1–3]. There are inconsistent data
on AE rates in subsequent VMMC programs [9–11]. A re-
view of VMMC task-shifting to studies revealed AE rates
from <1 to 38 % [12], and Kenyan programs documented
AE rates ranging from 1 to 18 % during early implementa-
tion [13, 14] to 3–7 % post scale-up [15]. No program
safety data from Malawi VMMC services have yet been
published [16].
Assuring high quality of delivered care represents a
substantial challenge in implementation of proven HIV
prevention interventions [16, 17]. Failure to make VMMC
services safe and patient-centered will impede further
scale-up of VMMC services. Monitoring to improve
service quality is one of seven pillars in the Joint Strategic
Action Framework to Accelerate the Scale-up of VMMC
for HIV Prevention in Eastern and Southern Africa [18].
Quality improvement (QI) activities, particularly those
that employ a structured, group problem-solving approach
[19, 20], have improved quality of care in varied settings.
We hypothesized that such approaches might improve
HIV prevention services in resource-limited settings. The
aim of this project was to employ a QI approach to assess
quality and safety of VMMC services and improve safety
outcomes at a VMMC program in Lilongwe, Malawi.
Methods
Study design
Utilizing a clinical case conference approach, a group
problem-solving, QI project involving retrospective chart
audits, case-conference AE classification, and provider
training was conducted at a VMMC clinic in Lilongwe,
Malawi. Evaluation of the QI project involved a quasi-
experimental pre/post design.
Population and setting
Bwaila VMMC Clinic is operated jointly by the University
of Washington International Training and Education
Center for Health (I-TECH) and the Malawi Ministry of
Health (MOH). The US Centers for Disease Control and
Prevention (CDC) in Malawi provides technical and pro-
grammatic support. The clinic opened in September 2012
and performs approximately 1000 VMMC procedures per
month. The clinic is located at a district hospital near the
city center in Malawi, where nurses and clinical officers are
trained to provide VMMC services using the forceps-
guided technique [21].
Of 894 clients undergoing VMMC in November 2012,
721 (81 %) returned for their scheduled 48-hour post-
operative visits, 491 (55 %) returned for their 7-day
visits, and 207 (23 %) returned for their 6-week visits.
This was representative of client follow-up throughout
the study period.
Data collection, clinical case conferences, and AE classification
A multi-disciplinary team of seven clinicians, monitoring
and evaluation staff, technical advisors, and program
managers audited the first 3000 client records for initial
review (the amount feasible in a 2-week audit). Charts
consisted of standardized forms provided by the MOH.
Information collected during the audit included client’s
reported reason for seeking VMMC, clinician-surgeon
name, duration of operation, and any indication of a
possible AE. In charts where possible AEs were identi-
fied, the team further recorded any available clinical
information including: detailed clinical notes, timing,
severity, progression, treatment, and outcomes.
Each day during the 2-week period, a case conference
was held with the entire VMMC program clinical team
and the multi-disciplinary audit team. Consistent with
previous clinical trial and the President’s Emergency
Plan for AIDS Relief (PEPFAR) definitions, the team
jointly classified each event as not related, possibly related,
or definitely related to the VMMC procedure. Each possible
or definitely related AE was further classified as: mild (re-
quiring only reassurance, monitoring, or local wound care);
moderate (requiring clinical support such as antibiotic
medication or additional suturing); or severe (requiring
return to the operating theater or hospitalization). Each
case was also reviewed to assess whether any treatment
provided was appropriate, and to determine lessons learned
for future management. These methods are generally con-
sistent with recommendations from the MOH and ap-
proaches used in two of the three randomized clinical trials
of VMMC to prevent HIV infection [1, 2, 21].
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During data collection and case conferences, providers
were also queried regarding lessons learned, challenges in
provision of care, and client flow was traced through the
clinic. After baseline evaluation, clinicians and managers
developed a QI plan to improve prevention, assessment,
and management of AEs. A repeat audit was conducted
6 months later, and proportions and severity of AEs before
and after the QI intervention were compared.
Data analysis
Data were analyzed using STATA SE v11.0 (StataCorp,
College Station, TX). Summary statistics were calculated,
and comparisons of AEs before and after the interven-
tion utilized chi-squared tests of proportions.
Ethical considerations
Clients consented to VMMC services through written
informed consent, and evaluation data were collected using
routine program tools. The Malawi National Health
Sciences Research Committee provided a letter of approval
for program evaluation and dissemination, and the
University of Washington Human Subjects Division
determined that study activities did not meet the regu-
latory definition of research under 45 CFR 46.102(d).
Results
Baseline audit
During baseline audits, we reviewed 3000 charts. Although
nurses and clinical officers are both trained to circumcise
clients in Malawi, the clinical officers conducted >90 % of
all surgeries. Client reason for presentation was only avail-
able for the first 2192 clients due to changes in MOH
forms. Overall, 67 % reported seeking VMMC for HIV or
sexually transmitted infection (STI) prevention. Hygiene
(11 %), medical (5 %), personal (5 %), and religious (4 %)
reasons were also cited. A small number indicated cancer
prevention (Table 1).
Of 3000 procedures, we initially documented 418
(13.9 %) possible AEs. As we began recording cases, we
found that most AEs were recorded as “infections” (5.4 %),
with varying descriptions ranging from, “mild inflamma-
tion,” to, “pus at the frenulum.” Nearly all of these, as well
as some not identified as AEs or infections in the chart,
were treated with antimicrobial drugs. The choice and dose
of antibiotics was surprising (e.g., oral ciprofloxacin and
metronidazole, plus intramuscular gentamicin), until we
learned that the staff had attended training on STI
management and we located the national guidelines for
urethral discharge, which included all of these drugs.
We also inspected drawers containing available antimi-
crobials and found that the only antimicrobials avail-
able at the clinic were those listed in the STI formulary.
Pseudo-outbreak investigation
We used sequential client identification (ID) numbers to
explore changes in rates over time. Spikes in rates of
AEs were consistent across VMMC providers, however
many cases appeared similar to the audit team. Although
the spikes were not associated with a particular surgeon,
they appeared to be related to the same clinician at the
post-operative visit. While MOH forms did not have a
space to enter post-operative visit clinician name or
initials, the handwriting was easily recognizable to the
audit team. We established a ‘case definition’ to explore
these spikes as if it were an ‘outbreak investigation,’
where cases met all of the following conditions: same
clinician handwriting, ‘infection’ diagnosed at post-operative
day 7, treated with ciprofloxacin and metronidazole, and
then ‘resolved’ at the next visit. We re-reviewed all ‘possible
AE’ charts and found that 289 (69 %) of the 418 met this
definition. Although the program employs more than 20
nurses and clinical officers, 152 (52.6 %) of these cases were
from the same nurse and highly suspicious for misdiag-
nosed infection. Further evidence included two charts
where a second nurse intervened and documented with-
holding antibiotics. During the audit process, clinicians
would also ask the consulting surgeon to review patients
identified as having possible infections. The surgeon found
that none of these clients showed signs of infection, rather
were displaying mild inflammation consistent with the heal-
ing process. We therefore excluded the 152 cases as
misclassification of infection.
AE rates and classification
Of the remaining 266 AEs, the team concluded that 257
(97 %) were procedure-related. Among the 257 procedure-
related AEs (8.6 per 100 VMMC procedures), 6 (0.2 %)
were classified as mild, 218 (7.3 %) were moderate, and 33
(1.1 %) were severe. Although some of the cases may have
been mild in presentation, the severity classification system
Table 1 AE Chart Audit Results from a VMMC Program
Lilongwe, Malawi (2012)
First audit Repeat audit p-value
n = 3000 n = 2540
Reason for seeking MC (n = 2192)
HIV/STI 1477 (67.4) -
Hygiene 246 (11.2) -
Medical 103 (4.7) -
Religious or Cultural 108 (4.9) -
Personal 104 (4.7) -
Other 154 (7.0) -
Possible Adverse Events 418 (13.9) 190 (7.5) <0.001
Case Conference Determination:
Related AE 257 (8.6) 115 (4.5) <0.001
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in use by VMMC programs assigns a severity level based
on the intervention and not necessarily the presentation.
Therefore even if the team assumed a mild presentation
based on the clinical report, a patient treated with antimi-
crobials was, by definition, assigned a moderate AE.
Clinical lessons learned
Case conference reviews concluded that 89 % of AEs were
not treated appropriately; the majority of these were pre-
scribed antibiotics for mild symptoms. Among 45 cases
deemed not to be AEs during case review, 36 (80 %) had
been prescribed antibiotics; 19 of 24 cases (79 %) desig-
nated as appropriately treated were given no antibiotics,
and all 170/170 cases (100 %) inappropriately treated were
given antibiotics (median two drugs per AE case).
Structural factors contributing to AE rates and management
Several structural factors were found to contribute to the
rates and misclassification of cases. Provider prescription
practices for management of post-operative inflammation
were consistent with national guidelines for urethral dis-
charge, available antibiotics were the STI formulary, and
providers reported feeling well-trained in surgical care but
insecure in skills related to post-operative assessment and
care. Wound care supplies, such as normal saline, irriga-
tion kits, or gauze, were limited in availability or stored in
another room, while antibiotics were in a nearby drawer.
Data quality
Although not the primary assessment of this audit, a
number of data-quality issues were identified. Client
identification numbers were assigned as clients were
entered into the national VMMC registers in the recov-
ery room. The client ID number corresponded to the
row number in the register, however in several cases,
the clinician had incorrectly entered or reversed the
digits of the ID number when moving to the next page
(e.g., 2441 becomes 2401), resulting in a large number
of clients with two different ID numbers, or different
clients with the same ID number, and a program mis-
count of the number of procedures. Other common
issues included: missing data as chart notes described
signs and symptoms of AEs without checking the box
indicating an AE was identified, database overwrite
issues as duplicate ID numbers were entered, and
version control with old versions of forms being printed
as supply of current forms ran out.
Quality improvement intervention
Clinical and program teams implemented a QI plan based
on several identified challenges. The first strategy was
grouped around post-operative assessment and manage-
ment. Providers expressed a lack of understanding of what
a normal healing adult circumcision should look like and a
need for a refresher in basic wound care training. Also of
concern was the limited availability of basic wound care
supplies. Staff expressed a desire to prioritize patient re-
assurance and basic wound hygiene before giving anti-
biotics, and agreed to query a second clinician prior to
prescribing antibiotics. Onsite technical in-service sur-
gical training in circumcision technique, assessment of
healing, and proper wound care was also provided. The
second strategy involved improvements in data entry
and classification of AEs. Providers agreed to continue
the case conference process, reviewing each potential
AE both for treatment and classification in order to
enhance clinical practice.
Subsequent audit to assess QI program
A repeat process 6 months after implementing the QI
program evaluated 2540 charts and identified 190 clients
(7.5 %) with possible AEs (Table 1). Subsequent discus-
sion in case conferences classified 123 clients to have
had an AE, including 115 considered procedure-related
events (4.5 per 100 VMMC procedures) (Table 2). Of
these 115 procedure-related AEs: 67 (2.6 %) were
Table 2 Characteristics of Related AEs Pre and Post-intervention
in a VMMC Program Lilongwe, Malawi (2012)
First audit Repeat audit p-value
n = 3,000 n = 2,540
Severity
Mild 6 (0.2) 67 (2.6) <0.001
Moderate 21 8 (7.3) 28 (1.1)
Severe 33 (1.1) 20 (0.8)
Reportable (Moderate & Severe) 251 (8.4) 48 (1.9) <0.001
Type of AE
Infection 161 (5.4) 46 (1.8) <0.001
Hematoma 24 (0.8) 0 (0.0)
Swelling 15 (0.5) 0 (0.0)
Bleeding 10 (0.3) 37 (1.5)
Wound disruption 2 (0.1) 16 (0.6)
Delayed wound healing 12 (0.4) 3 (0.1)
Damage to penis 3 (0.1) 1 (0.04)
Insufficient skin removal 4 (0.1) 3 (0.1)
Pain 0 (0.0) 5 (0.2)
Urethral fistula 0 (0.0) 1 (0.04)
Poor appearance 1 (0.03) 0 (0.0)
Nonspecific or Unable to
assess






Appropriately treated 25 (9.7) 108 (93.9) <0.001
Median (range) number of
drugs/AE
2 (0–5) 1 (1–2) <0.001
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classified as mild, 28 (1.1 %) moderate, and 20 (0.9 %)
severe. Program-reportable (moderate and severe) AEs
totaled 48 (1.9 per 100 VMMC procedures). Severity dis-
tribution and overall number of reportable AEs were sig-
nificantly reduced (both p < 0.001). The follow up audit
also identified changes in specific AE types, with fewer
cases of infection (5.4 % before vs. 1.8 % after) and a
higher proportion of bleeding cases (0.3 % before vs.
1.5 %) after the intervention. Overall rates of total AEs
had decreased by 48 % (from 8.6 to 4.5 per 100 VMMC
procedures, p < 0.001) and moderate-plus-severe (pro-
gram-reportable) AEs decreased by 75 % (from 8.4 to 1.9
per 100 VMMC procedures, p < 0.001).
Discussion
The initial review of the VMMC program caused concern
because of a high rate of AEs compared to the rates
observed in clinical trials (14 % compared to a range of
1–8 %). This concern led to a detailed review of 3000
initial patient charts on a line-by-line basis. We identified
a ‘pseudo-outbreak’ that was not associated with particular
VMMC surgical service providers, but with post-operative
assessment and likely misclassification of normal events as
“severe or moderate” AEs. Our detailed review identified a
number of easily achievable changes that we targeted for
our QI intervention. None of these activities targeted the
surgical procedure, but rather the assessment, clinical
management, and documentation of events.
The first area was to improve staff training and educa-
tion on post-operative wound assessment and wound care.
While wound care in general is a part of nursing and clin-
ical officer curricula, adult male circumcisions are rela-
tively new procedures to these cadres of clinicians. An
emphasis on training for the surgical procedure is key and
was generally well provided by our national program.
However, we identified the need for additional staff train-
ing in assessment and management of post-operative
wound care, with an emphasis on local wound care only
for patients with mild postoperative inflammation or mild
infections, such as a stitch abscess, rather than prescrip-
tion of multiple antimicrobials.
The identified possible ‘wound infections’ routinely
treated with multiple antimicrobials often were described
as post-operative inflammation or other mild symptoms
that would likely respond to local wound care alone. The
Infectious Diseases Society of America’s updated 2014
guidelines for diagnosis and management of skin and soft
tissue infections state that antimicrobials are not indicated
for surgical site infections in the absence of fever or
systemic symptoms [22]. Excessive use of antimicrobials is
consistent with findings from other settings and with local
clinical practice. While we aimed to decrease the number
of antimicrobials prescribed, a few programs have re-
ported isolated cases of Fournier’s gangrene after surgical
circumcision [23], so there may be some benefit to more
broad antimicrobial coverage in addition to secondary sur-
gical management in highly selected cases. This must be
balanced with concerns for promoting emergence of anti-
biotic resistance and over use of antibiotics.
The second area of improvement was related to AE
documentation and classification. Most of the charts of
moderate AE cases described no or mild symptoms, how-
ever the AE became classified as moderate due to the
medical intervention of prescribing antimicrobials. A
reporting classification system that determines AE severity
based on the treatment provided, and not the symptoms
assessed, will lead to increased rates of reported AEs if
providers tend to rely on excessive use of antimicrobials.
Classification systems that focus more specifically on as-
sessment rather than treatment to categorize events will
be useful for Malawi and other VMMC programs.
Finally, while there is no tradition of a “case conference
for QI” in Malawi, the QI group-problem solving process
appeared to provide a successful approach to improve
quality of clinical care by engaging the clinical team in
discussions of program outcomes. Our experience was
that the team took ownership of program and that the use
of data in program operations provided a framework for
continued improvement.
This study has several strengths and limitations. This
QI process was unique in that it included a detailed and
thorough review of more than 5000 client charts, and
utilized a team-based approach that bridged clinical and
evaluation personnel for a common purpose. Several
data quality issues were identified in the process of the
audit, however we were not able to quantify these errors.
While our repeat audit AE numbers are reassuring, a re-
cent study from Kenya suggests that AE rates may be
higher than reported given the context of low rates of client
follow up in clinic (6.8 AE per 100 VMMC procedures in
the lost to follow up group compared to 3.3 AE per 100
VMMC procedures in the adherent to follow up group)
[15]. In our program, 7-day follow up rates are 55 %, sug-
gesting the possibility of similar under-reporting in Malawi.
Given the rapidly changing service delivery environment,
attribution of the temporal improvement in AE rates to our
QI process must be interpreted with caution. Furthermore,
it is unclear how much of the improvement could be attrib-
uted to changes in post-operative clinical service versus
improved data collection and AE classification.
Conclusions
AE rates from this implementation site are within range of
clinical trial experiences. However, we detected problems
with post-operative assessment, clinical management, and
documentation of AEs. Our QI process significantly
decreased the rates of overall and of program-reportable
AEs, resulting in improved clinical assessment and post-
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operative management, as well as more accurate program
reporting. A similar process could benefit other VMMC
programs. Lessons learned from this process are likely to
apply to provision of VMMC services during VMMC roll-
out in other resource-limited settings.
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